DSIP, what the science actually shows

DSIP (Delta Sleep-Inducing Peptide) is a neuropeptide studied for sleep regulation and stress response. Not FDA-approved. Evidence base: some human studies but results are inconsistent across trials.

A 9-amino-acid neuropeptide isolated from rabbit brain in 1977. Named for inducing delta wave (deep) sleep in animal models. The research is intriguing but limited.

Evidence
★★☆☆☆ Limited
Type
Neuropeptide
Structure
9 amino acids

What DSIP is

DSIP was first isolated in 1977 by Swiss researchers from rabbit blood during electrically induced sleep. Sequence: Trp-Ala-Gly-Gly-Asp-Ala-Ser-Gly-Glu. Found in hypothalamus and pituitary. Named because injecting it into rabbits increased delta wave (deepest non-REM sleep) activity.

Mechanism, in plain English

Not fully mapped. Known actions: modulates GABA-A receptors, influences corticotropin and cortisol release, affects LH secretion, may interact with opioid receptors. Rather than a simple 'sleep switch,' DSIP appears to be a stress-buffering and circadian-modulating peptide that promotes sleep indirectly by reducing stress hormones and normalizing disrupted rhythms.

Want all sleep stress compounds in one place?

Get the Sleep & Stress Management Guide →

What the evidence shows

Early animal studies showed increased delta sleep and reduced sleep latency. Small human studies (1980s-1990s, European) reported improved sleep quality in insomnia and normalized patterns in narcolepsy. Most human data from small, older studies. No large RCTs exist. Rapid degradation in blood complicates research.

FDA status

Not FDA-approved. Limited active clinical research.

Common synonyms

DSIP, delta sleep-inducing peptide, Emideltide (analogue)

Safety and adverse-event landscape

Small studies report no serious adverse events. Very short half-life. Long-term safety data essentially absent.

Frequently asked questions

Animal data consistently shows increased delta waves. Human data is limited but suggestive, possibly better for disrupted sleep (stress, shift work).
Rapid blood degradation, synthesis difficulty, and original researchers not pursuing commercial development.
No evidence of dependence or tolerance. Does not appear to disrupt natural sleep architecture.
No. Peptexa is educational only.

Related on Peptexa

Selank. Anxiolytic peptide All sleep and stress peptides Take the peptide quiz

The full Sleep & Stress Management reference

Mechanism, evidence level, and FDA status for every compound.

Get the Sleep & Stress Management Guide →